EUROFINS SCIENTIFIC (ERF.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ERF • FR0014000MR3

67.44 EUR
+0.22 (+0.33%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

ERF gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 21 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ERF get a neutral evaluation. Nothing too spectacular is happening here. ERF has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ERF had positive earnings in the past year.
  • ERF had a positive operating cash flow in the past year.
  • Each year in the past 5 years ERF has been profitable.
  • ERF had a positive operating cash flow in each of the past 5 years.
ERF.PA Yearly Net Income VS EBIT VS OCF VS FCFERF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • The Return On Assets of ERF (6.29%) is better than 76.19% of its industry peers.
  • With a decent Return On Equity value of 15.21%, ERF is doing good in the industry, outperforming 76.19% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 11.61%, ERF belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
ROA 6.29%
ROE 15.21%
ROIC 11.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ERF.PA Yearly ROA, ROE, ROICERF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ERF has a Profit Margin of 6.48%. This is comparable to the rest of the industry: ERF outperforms 42.86% of its industry peers.
  • In the last couple of years the Profit Margin of ERF has declined.
  • ERF has a Operating Margin of 12.42%. This is in the lower half of the industry: ERF underperforms 66.67% of its industry peers.
  • ERF's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 22.25%, ERF is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ERF has declined.
Industry RankSector Rank
OM 12.42%
PM (TTM) 6.48%
GM 22.25%
OM growth 3Y-11.06%
OM growth 5Y-10.4%
PM growth 3Y-9.05%
PM growth 5Y-6.87%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
ERF.PA Yearly Profit, Operating, Gross MarginsERF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ERF is creating some value.
  • ERF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ERF.PA Yearly Shares OutstandingERF.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ERF.PA Yearly Total Debt VS Total AssetsERF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • ERF has an Altman-Z score of 3.05. This indicates that ERF is financially healthy and has little risk of bankruptcy at the moment.
  • ERF has a Altman-Z score (3.05) which is in line with its industry peers.
  • ERF has a debt to FCF ratio of 5.14. This is a neutral value as ERF would need 5.14 years to pay back of all of its debts.
  • ERF has a Debt to FCF ratio of 5.14. This is in the better half of the industry: ERF outperforms 66.67% of its industry peers.
  • ERF has a Debt/Equity ratio of 0.82. This is a neutral value indicating ERF is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.82, ERF perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 3.05
ROIC/WACC1.23
WACC9.45%
ERF.PA Yearly LT Debt VS Equity VS FCFERF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that ERF should not have too much problems paying its short term obligations.
  • The Current ratio of ERF (1.09) is comparable to the rest of the industry.
  • A Quick Ratio of 1.03 indicates that ERF should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.03, ERF perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ERF.PA Yearly Current Assets VS Current LiabilitesERF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.73% over the past year.
  • ERF shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.23% yearly.
  • ERF shows a strong growth in Revenue. In the last year, the Revenue has grown by 53.32%.
  • The Revenue has been growing slightly by 6.05% on average over the past years.
EPS 1Y (TTM)12.73%
EPS 3Y-4.43%
EPS 5Y-0.23%
EPS Q2Q%6.78%
Revenue 1Y (TTM)53.32%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%

3.2 Future

  • ERF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.10% yearly.
  • Based on estimates for the next years, ERF will show a small growth in Revenue. The Revenue will grow by 7.79% on average per year.
EPS Next Y10.84%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
EPS Next 5Y15.1%
Revenue Next Year5.78%
Revenue Next 2Y6.35%
Revenue Next 3Y7.37%
Revenue Next 5Y7.79%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERF.PA Yearly Revenue VS EstimatesERF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ERF.PA Yearly EPS VS EstimatesERF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.13, ERF is valued on the expensive side.
  • ERF's Price/Earnings ratio is rather cheap when compared to the industry. ERF is cheaper than 80.95% of the companies in the same industry.
  • ERF is valuated rather cheaply when we compare the Price/Earnings ratio to 28.03, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 16.69, ERF is valued correctly.
  • Based on the Price/Forward Earnings ratio, ERF is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, ERF is valued a bit cheaper.
Industry RankSector Rank
PE 18.13
Fwd PE 16.69
ERF.PA Price Earnings VS Forward Price EarningsERF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 90.48% of the companies in the same industry are more expensive than ERF, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ERF is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.24
EV/EBITDA 8.13
ERF.PA Per share dataERF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ERF's earnings are expected to grow with 15.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.67
PEG (5Y)N/A
EPS Next 2Y12.5%
EPS Next 3Y15.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • ERF has a Yearly Dividend Yield of 1.05%.
  • ERF's Dividend Yield is rather good when compared to the industry average which is at 0.44. ERF pays more dividend than 85.71% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, ERF's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.05%

5.2 History

  • The dividend of ERF is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ERF.PA Yearly Dividends per shareERF.PA Yearly Dividends per shareYearly Dividends per share 2018 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ERF pays out 15.92% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of ERF is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP15.92%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
ERF.PA Yearly Income VS Free CF VS DividendERF.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ERF.PA Dividend Payout.ERF.PA Dividend Payout, showing the Payout Ratio.ERF.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EUROFINS SCIENTIFIC

EPA:ERF (2/10/2026, 7:00:00 PM)

67.44

+0.22 (+0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)07-21
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.28B
Revenue(TTM)10.66B
Net Income(TTM)691.00M
Analysts68.42
Price Target70.01 (3.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.05%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP15.92%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.51%
PT rev (3m)8.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.47%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.13
Fwd PE 16.69
P/S 1.15
P/FCF 14.24
P/OCF 8.77
P/B 2.7
P/tB N/A
EV/EBITDA 8.13
EPS(TTM)3.72
EY5.52%
EPS(NY)4.04
Fwd EY5.99%
FCF(TTM)4.74
FCFY7.02%
OCF(TTM)7.69
OCFY11.4%
SpS58.51
BVpS24.95
TBVpS-4.41
PEG (NY)1.67
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 6.29%
ROE 15.21%
ROCE 15.48%
ROIC 11.61%
ROICexc 12.8%
ROICexgc 41.1%
OM 12.42%
PM (TTM) 6.48%
GM 22.25%
FCFM 8.1%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.06%
OM growth 5Y-10.4%
PM growth 3Y-9.05%
PM growth 5Y-6.87%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 1.9
Cap/Depr 85.24%
Cap/Sales 5.04%
Interest Coverage 11.51
Cash Conversion 71.65%
Profit Quality 124.89%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 3.05
F-Score6
WACC9.45%
ROIC/WACC1.23
Cap/Depr(3y)81.48%
Cap/Depr(5y)89.24%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.16%
Profit Quality(3y)196.03%
Profit Quality(5y)160.87%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-4.43%
EPS 5Y-0.23%
EPS Q2Q%6.78%
EPS Next Y10.84%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
EPS Next 5Y15.1%
Revenue 1Y (TTM)53.32%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year5.78%
Revenue Next 2Y6.35%
Revenue Next 3Y7.37%
Revenue Next 5Y7.79%
EBIT growth 1Y27.19%
EBIT growth 3Y-8.55%
EBIT growth 5Y-4.98%
EBIT Next Year83.08%
EBIT Next 3Y29.99%
EBIT Next 5Y25.16%
FCF growth 1Y9.17%
FCF growth 3Y21.94%
FCF growth 5Y-0.12%
OCF growth 1Y6.15%
OCF growth 3Y7.21%
OCF growth 5Y2.73%

EUROFINS SCIENTIFIC / ERF.PA FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.


What is the valuation status for ERF stock?

ChartMill assigns a valuation rating of 6 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for EUROFINS SCIENTIFIC?

EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 4 / 10.


What is the earnings growth outlook for EUROFINS SCIENTIFIC?

The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 10.84% in the next year.


Can you provide the dividend sustainability for ERF stock?

The dividend rating of EUROFINS SCIENTIFIC (ERF.PA) is 5 / 10 and the dividend payout ratio is 15.92%.